NCT00449410View on ClinicalTrials.gov

Silent Cerebrovascular Lesion and Cognitive Decline Prevention by Cholesterol Lowering in Elderly AF Patients

PHASE4CompletedINTERVENTIONAL

Enrollment

35

Participants

Timeline

Start Date

May 31, 2005

Study Completion Date

October 31, 2006

Conditions

Atrial FibrillationNeuropsychologyMagnetic Resonance ImagingInflammationHemostasis

Interventions

DRUG

Atorvastatin

DRUG

ezetimibe

Trial Locations (1)

6500 HB

Gheorghe AM Pop, Nijmegen

Sponsors

Collaborators (2)

Schering-Plough

All Listed Sponsors

collaborator

Pfizer

INDUSTRY

collaborator

Schering-Plough

INDUSTRY

lead

Radboud University Medical Center

OTHER